United Kingdom (GB)

Can Non-specialists Provide High Quality Gold Standard Labels in Challenging Modalities? (2021) Budd S, Day TG, Simpson JM, Lloyd K, Matthew J, Skelton E, Razavi R, Kainz B Authored book, Volume of book series Ultrasound Video Transformers for Cardiac Ejection Fraction Estimation (2021) Reynaud H, Vlontzos A, Hou B, Beqiri A, Leeson P, Kainz B Authored book, Volume of book series Detecting Hypo-plastic Left Heart Syndrome in Fetal Ultrasound via Disease-Specific Atlas Maps (2021) Budd S, Sinclair M, Day TG, Vlontzos A, Tan J, Liu T, Matthew J, et al. Authored book, Volume of book series Association of quality of life (QOL) with overall survival (OS) in patients (pts) with HR+/HER2-advanced breast cancer (ABC) treated with ribociclib (RIB) plus endocrine therapy (ET) in the MONALEESA-3 (ML-3) and ML-7 trials (2021) Fasching P, Harbeck N, Jerusalem G, Colleoni MA, Neven P, Franke F, De Laurentiis M, et al. Conference contribution The phase III NETTER-1 study of 177Lu-DOTATATE in patients with midgut neuroendocrine tumours: Further survival analyses (2021) Ruszniewski PB, Caplin ME, Kunz PL, Bodei L, Hendifar AE, Mittra E, Wolin EM, et al. Conference contribution PACIFIC-R real-world study: Treatment duration and interim analysis of progression-free survival in unresectable stage III NSCLC patients treated with durvalumab after chemoradiotherapy (2021) Girard N, Smit HJM, Sibille A, Mcdonald F, Mornex F, Garassino MCC, Filippi AR, et al. Conference contribution Care for neuroendocrine tumor patients, monitored by medical oncologists: Comparative data Europe vs North America (2021) Kolarova T, Mcdonnell M, Bouvier CV, Pavel ME, Singh H, Howe J, Singh S, et al. Conference contribution Results of a randomized phase II study comparing pembrolizumab with methotrexate in elderly, frail or cisplatin-ineligible patients with relapsed or metastatic squamous cell carcinoma of the head and neck (RM-SCCHN) (ELDORANDO-AIO-KHT-0115) (2021) Gruenwald V, Graeven U, Ivanyi P, Dietz A, Hahn D, Hackenberg S, Kasper S, et al. Conference contribution COVID-19 pandemic impact on healthcare professionals treating patients with neuroendocrine tumors (NET): An international NET CONNECT survey (2021) Hernando J, Lamarca A, Cives M, Caplin ME, Pavel ME Conference contribution Neutral sphingomyelinase mediates the co-morbidity trias of alcohol abuse, major depression and bone defects (2021) Kalinichenko L, Mühle C, Jia T, Anderheiden F, Datz M, Eberle AL, Eulenburg V, et al. Journal article